Stigmatisation in onychomycosis patients: A population-based study

Mycoses

Volumn 52, Issue 4, 2009, Pages 343-349

  Szepietowski, Jacek C ^a   Reich, Adam ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Fungal infection; Nails; Stigmatisation

Indexed keywords

AMOROLFINE; ONYMAX; TERBINAFINE; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; DISEASE DURATION; EDUCATIONAL STATUS; FEMALE; FINGERNAIL ONYCHOMYCOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE; STIGMA; TOENAIL ONYCHOMYCOSIS; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; ONYCHOMYCOSIS; POLAND; PROSPECTIVE STUDIES; QUESTIONNAIRES; STEREOTYPING; YOUNG ADULT;

EID: 67249118702     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2008.01618.x     Document Type: Article

References (22)

1. Effendy I, Lecha M, Feuilhade de Chauvin M, Di Chiacchio N, Baran R. European Onychomycosis Observatory. Epidemiology and clinical classification of onychomycosis. J Eur Acad Dermatol Venereol 2005 19 (Suppl. 1 8 12.
2. Roberts DT. Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an omnibus survey. Br J Dermatol 1992 126 : 23 37.
3. Heikkilä H, Stubbs S. The prevalence of onychomycosis in Finland. Br J Dermatol 1995 133 : 699 701.
4. Szepietowski JC, Reich A, Garłowska E, Kulig M, Baran E. Factors influencing coexistence of toenail onychomycosis with tinea pedis and other dermatomycoses: a survey of 2761 patients. Arch Dermatol 2006 142 : 1279 84.
5. Roujeau JC, Sigurgeirsson B, Korting HC, Kerl H, Paul C. Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulites of the leg: a case-control study. Dermatology 2004 209 : 301 7.
6. Bonifaz A, Paredes V, Fierro L. Onychocryptosis as consequence of effective treatment of dermatophytic onychomycosis. J Eur Acad Dermatol Venereol 2007 21 : 699 700. (Pubitemid 46916781)
7. Scher RK. Onychomycosis is more than a cosmetic problem. Br J Dermatol 1994 43 : 15. (Pubitemid 24203328)
8. Lubeck DP, Patrick DL, McNulty P, Fifer SK, Birnbaum J. Quality of life of persons with onychomycosis. Qual Life Res 1993 2 : 341 8.
9. Drake LA, Patrick DL, Fleckman P et al. The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life. J Am Acad Dermatol 1999 41 : 189 96.
10. Shaw JW, Joish VN, Coons SJ. Onychomycosis: health-related quality of life considerations. Pharmacoeconomics 2002 20 : 23 36. (Pubitemid 34155213)
11. Szepietowski JC, Reich A, Woźniak M, Baran E. Evaluation of quality of life in patients with onychomycosis using the Polish version of Dermatology Life Quality Index. Mikol Lek 2006 13 : 193 8.
12. Szepietowski JC, Reich A, Pacan P, Garlowska E, Baran E, on behalf of the Polish Onychomycosis Study Group. Evaluation of quality of life in patients with toenail onychomycosis by Polish version of an international onychomycosis-specific questionnaire. J Eur Acad Dermatol Venereol 2007 21 : 491 6.
13. Potter LP, Mathias SD, Raut M, Kianifard F, Tavakkol A. The OnyCOE-t™ questionnaire: responsiveness and clinical meaningfulness of patient-reported outcomes questionnaire for toenail onychomycosis. Health Qual Life Outcomes 2006 4 : 50.
14. Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol 1989 20 : 53 63. (Pubitemid 19033846)
15. Szepietowski J, Reich A. Combined treatment of toenail onychomycosis with terbinafine and amorolfine: prospective open-label study. Klin Dermatol 2008 10 : 55 60.
16. Hrehorów E, Szepietowski J, Reich A, Evers AWM, Ginsburg IH. Instruments for stigmatization evaluation in patients suffering from psoriasis: Polish language version. Dermatol Klin 2006 8 : 253 8.
17. Lu Y, Duller P, van der Valk PGM, Evers AWM. Helplessness as predictor of perceived stigmatization in patients with psoriasis and atopic dermatitis. Dermatol Psychosom 2003 4 : 146 50.
18. Hrechorow E, Reich A, Szepietowski JC. Stigmatization in psoriatic patients. Dermatol Klin 2007 9 (Suppl. 1 25.
19. Drake L. Quality of life issues for patients with fungal nail infections. AIDS Patient Care 1995 9 (Suppl. 1 S15 7.
20. Firooz A, Khamesipour A, Dowlati Y. Itraconazole pulse therapy improves the quality of life of patients with toenail onychomycosis. J Dermatolog Treat 2003 14 : 95 8.
21. Tabolli S, Alessandroni L, Gaido J, Sampogna F, Di Pietro C, Abeni D. Health-related quality of life and nail disorders. Acta Derm Venereol 2007 87 : 255 9.
22. Warshaw EM, Foster JK, Cham PM, Grill JP, Chen SC. NailQoL: a quality-of-life instrument for onychomycosis. Int J Dermatol 2007 46 : 1279 86.